SecBot SecBot
PRESS-RELEASE ·Filed Jun 1, 2026

SNN

Smith & Nephew UK Ltd
BULLISH
Impact 5/10
Horizonmonths Processed5mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight ▲ Bullish

Monitor adoption metrics and any revenue contribution from LEAF in upcoming quarterly reports. The launch is a positive signal for Smith+Nephew's wound management innovation pipeline but is unlikely to materially move the stock given the company's large revenue base. Watch for competitor responses in the pressure injury prevention space.

DirectionBullish
Confidencemedium
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$29.48
T+0 close · Jun 1, 2026 · via day close
Latest settled
−0.88%
T+60 · $29.22
Vs SPY
−2.11%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 1 $29.48entry
  2. T+1 · 6mo ago −0.41%α −0.55% · $29.36
  3. T+5 · 5mo ago +3.83%α +6.58% · $30.61
  4. T+20 · 5mo ago −2.27%α −0.97% · $28.81
  5. T+60 · 3mo ago −0.88%α −2.11% · $29.22
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Smith+Nephew announced the US launch of the next-generation LEAF Patient Monitoring System, a cloud-based platform using wearable sensors to reduce hospital-acquired pressure injuries (HAPIs). The system claims up to 73% reduction in HAPI odds and up to $1.8 million in estimated savings per critical care facility, addressing a $26.8B annual US burden. This product launch is a positive incremental catalyst for Smith+Nephew's Advanced Wound Management segment but does not materially change the company's overall $6.2B revenue base.

Key Financial Metrics

Revenue
$6.2B

Key Facts

  • LEAF Next Generation is now commercially available in the US.
  • System uses a wearable sensor to monitor patient mobility and provide real-time turn status updates.
  • Claims to reduce odds of HAPIs by up to 73% vs standard of care.
  • Delivers up to $1.8 million in estimated savings in one critical care facility.
  • HAPIs place a $26.8B annual burden on the US economy.
  • Smith+Nephew generated annual sales of $6.2 billion in 2025.
  • Product is cloud-hosted and integrates with hospital EMRs.

Financial Impact

Up to $1.8 million in estimated savings per critical care facility; $26.8B annual US HAPI burden addressed; product launch is incremental to $6.2B total revenue.

revenuemarket share in wound management

Risk Factors

  • Adoption may be slower than expected due to hospital budget constraints or workflow integration challenges.
  • Competing technologies could limit market share gains.
  • No financial guidance or revenue targets were provided for the product.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
54% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3304677

Track record

42 reports on SNN

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
  2. Nov 4, 202612d ago 6-K Bearish 6/10 No price data
  3. Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
  4. Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
  5. Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
  6. Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
  7. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  8. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  9. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
  10. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
Showing 10 of 42

US Market Status

Market Closed · Opens Wed (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026